A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Meyniel, Jean Philippe ^a   Cottu, Paul H ^a   Decraene, Charles ^a,b   Stern, Marc Henri ^a,c   Couturier, Jérôme ^a   Lebigot, Ingrid ^a   Nicolas, André ^a   Weber, Nina ^a   Fourchotte, Virginie ^a   Alran, Séverine ^a   Rapinat, Audrey ^a   Gentien, David ^a   Roman Roman, Sergio ^a   Mignot, Laurent ^a   Sastre Garau, Xavier ^a  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; FEMALE; GENE MAPPING; GENETIC ALGORITHM; GENOME ANALYSIS; GENOMICS; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; OVARY METASTASIS; PRIMARY TUMOR; SECOND CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; ALGORITHM; BREAST TUMOR; CANCER STAGING; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SCREENING; GENETICS; IMMUNOHISTOCHEMISTRY; METASTASIS; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; TIME;

ADULT; AGED; ALGORITHMS; BREAST NEOPLASMS; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 77952438343     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-222     Document Type: Article

References (23)

1. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006, 56:37-47. 10.3322/canjclin.56.1.37, 16449185.
2. Högberg T, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in ovarian cancer. Acta Oncol 2001, 40:340-360. 10.1080/02841860151116420, 11441940.
3. Turan T, Aykan B, Koc S, Boran N, Tulunay G, Karacay O, Erdogan Z, Kose F. Analysis of metastatic ovarian tumors from extragenital primary sites. Tumori 2006, 92:491-495.
4. Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984, 53:1978-1984. 10.1002/1097-0142(19840501)53:9<1978::AID-CNCR2820530929>3.0.CO;2-1, 6322966.
5. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2004, 93:87-91. 10.1016/j.ygyno.2003.12.039, 15047218.
6. Le Thai N, Lasry S, Brunet M, Harvey P, Rouesse J. Cancer of the ovary after cancer of the breast. 45 cases [Article in French]. J Gynecol Obstet Biol Reprod (Paris) 1991, 20:1043-1048.
7. Young RH. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary - Part II. Adv Anat Pathol 2007, 14:149-177. 10.1097/PAP.0b013e3180504abf, 17452813.
8. Levy-Lahad E, Friedman E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 2007, 96:11-15. 10.1038/sj.bjc.6603535, 2360226, 17213823.
9. Harris M, Howell A, Chrissohou M, Swindel RIC, Hudson M, Sellwood RA. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984, 50:23-30. 1976917, 6331484.
10. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996, 77:113-120. 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8, 8630916.
11. Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008, 32:1566-1571. 10.1097/PAS.0b013e31816d71ad, 18724243.
12. Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, Norton L, Tan LK. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 2005, 29:1482-1489. 10.1097/01.pas.0000176429.88702.36, 16224215.
13. Mhawech-Fauceglia P, Rai H, Nowak N, Cheney RT, Rodabaugh K, Lele S, Odunsi K. The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus. Histopathology 2008, 53:490-495. 10.1111/j.1365-2559.2008.03107.x, 18643851.
14. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007, 18:1133-144. 10.1093/annonc/mdm271, 17675394.
15. Rigaill G, Hupé P, Almeida A, La Rosa P, Meyniel JP, Decraene C, Barillot E. ITALICS: an algorithm for normalization and DNA copy number calling for Affymetrix SNP arrays. Bioinformatics 2008, 24:768-774. 10.1093/bioinformatics/btn048, 18252739.
16. Hupé P, Stransky N, Thiery JP, Radvanyi F, Barillot E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004, 20:3413-3422. 10.1093/bioinformatics/bth418, 15381628.
17. La Rosa P, Viara E, Hupé P, Pierron G, Liva S, Neuvial P, Brito I, Lair S, Servant N, Robine N, Manié E, Brennetot C, Janoueix-Lerosey I, Raynal V, Gruel N, Rouveirol C, Stransky N, Stern MH, Delattre O, Aurias A, Radvanyi F, Barillot E. VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 2006, 22:2066-2073. 10.1093/bioinformatics/btl359, 16820431.
18. Wu Z, Irizarry RA. Preprocessing of oligonucleotide array data. Nat Biotechnol 2004, 22:656-658. 10.1038/nbt0604-656b, 15175677.
19. MacDonald JW, Ghosh D. COPA--cancer outlier profile analysis. Bioinformatics 2006, 22:2950-2951. 10.1093/bioinformatics/btl433, 16895932.
20. Nishizaki T, DeVries S, Chew K, Goodson WH, Ljung BM, Thor A, Waldman FM. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997, 19:267-272. 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V, 9258662.
21. Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl T, Henner WD, Sciulli C, Dumur CI, Medeiros F, Anderson GG. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J Clin Oncol 2009, 27:2503-2507. 10.1200/JCO.2008.17.9762, 19332734.
22. Madore J, Ren F, Filali-Mouhim A, Sanchez L, Köbel M, Tonin PN, Huntsman D, Provencher DM, Mes-Masson AM. Characterisation of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma. J Pathol 2010, 220:382-400.
23. Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho K. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/β-catenin and PI3K/Pten signaling pathways. Cancer Cell 2007, 11:321-333. 10.1016/j.ccr.2007.02.016, 17418409.